Morinaga Milk Industry Co., Ltd. Stock

Equities

2264

JP3926800008

Food Processing

Market Closed - Japan Exchange 02:00:00 2024-04-19 am EDT 5-day change 1st Jan Change
2,980 JPY -1.13% Intraday chart for Morinaga Milk Industry Co., Ltd. -4.70% +9.24%
Sales 2024 * 548B 3.55B Sales 2025 * 560B 3.63B Capitalization 262B 1.69B
Net income 2024 * 62.54B 405M Net income 2025 * 18.9B 122M EV / Sales 2024 * 0.52 x
Net Debt 2024 * 25.01B 162M Net Debt 2025 * 29.95B 194M EV / Sales 2025 * 0.52 x
P/E ratio 2024 *
4.22 x
P/E ratio 2025 *
13.7 x
Employees 7,040
Yield 2024 *
1.99%
Yield 2025 *
2.22%
Free-Float 86.11%
More Fundamentals * Assessed data
Dynamic Chart
Morinaga Milk Industry Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Morinaga Milk Industry Relocates Headquarters to a Newer Building in Minato-ku, Tokyo MT
Morinaga Milk Industry Co., Ltd. Announces Change of Address CI
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium B-3 Receives Approval of Individual Recognized Registration in South Korea CI
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. CI
Morinaga Milk Industry Co., Ltd.'s Equity Buyback announced on May 15, 2023, has closed with 1,856,400 shares, representing 4.14% for ¥9,999.53 million. CI
Morinaga Milk Industry Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Morinaga Milk Industry Co., Ltd. Revises Earnings Guidance for the First Six Months Ended September 30, 2023 and for the Fiscal Year Ending March 31, 2024 CI
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. CI
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium Longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil CI
Morinaga Milk Industry Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2024 CI
Morinaga Milk Industry Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Morinaga Milk Industry Issues Restricted Stock Compensation MT
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. CI
Morinaga Milk Industry Co., Ltd. completed the acquisition of 20% stake in Morinaga Le May Vietnam Joint Stock Company from Le Van May and Do Thanh Tuan. CI
More news
1 day-1.13%
1 week-4.70%
Current month-4.67%
1 month-3.65%
3 months+1.90%
6 months+10.74%
Current year+9.24%
More quotes
1 week
2 945.00
Extreme 2945
3 125.00
1 month
2 945.00
Extreme 2945
3 246.00
Current year
2 740.50
Extreme 2740.5
3 246.00
1 year
2 295.00
Extreme 2295
3 246.00
3 years
1 982.50
Extreme 1982.5
3 690.00
5 years
1 607.50
Extreme 1607.5
3 690.00
10 years
845.00
Extreme 845
3 690.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
President 64 83-03-31
Chairman 73 75-03-31
Members of the board TitleAgeSince
Director/Board Member 74 15-05-31
Chairman 73 75-03-31
Director/Board Member 78 15-05-31
More insiders
Date Price Change Volume
24-04-19 2,980 -1.13% 297 300
24-04-18 3,014 +1.43% 336,300
24-04-17 2,972 -0.83% 396,800
24-04-16 2,996 -2.58% 303,500
24-04-15 3,076 -1.63% 259,800

Delayed Quote Japan Exchange, April 19, 2024 at 02:00 am EDT

More quotes
Morinaga Milk Industry Co., Ltd. is a Japan-based company mainly engaged in the food business. The Company is mainly engaged in the manufacture and sale of milk products, dairy products, beverages, yogurt products, desserts, ice cream products, condensed milk products, cheese, butter, baby food, health food and other products. The Company is also engaged in the purchase and sale of feed products and pet food, the design and construction of plant facilities, the rental of real estate, as well as the transportation and warehousing business.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
3,014 JPY
Average target price
3,326 JPY
Spread / Average Target
+10.35%
Consensus